D. Verlaan

发表

A probabilistic approach for SNP discovery in high-throughput human resequencing data.

K. Dewar, M. Blanchette, T. Pastinen, 2009, Genome research.

Hundreds of variants clustered in genomic loci and biological pathways affect human height

Ayellet V. Segrè, Cameron D. Palmer, P. Elliott, 2010, Nature.

Global patterns of cis variation in human cells revealed by high-density allelic expression analysis

Mathieu Blanchette, Daniel Sinnett, Ken Dewar, 2009, Nature Genetics.

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture

Daniel L. Koller, David M. Evans, D. Kiel, 2012, Nature Genetics.

The proportion of mutations predicted to have a deleterious effect differs between gain and loss of function genes in neurodegenerative disease

D. Verlaan, G. Rouleau, P. Valdmanis, 2009, Human mutation.

Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease.

K. Dewar, M. Świątek, J. Celedón, 2009, American journal of human genetics.

Population genomics in a disease targeted primary cell model.

Daniel Sinnett, Fernando Rivadeneira, Claes Ohlsson, 2009, Genome research.

Krit1 missense mutations lead to splicing errors in cerebral cavernous malformation.

D. Verlaan, A. Siegel, G. Rouleau, 2002, American journal of human genetics.

Mutations in Krit1

D. Verlaan, 2002 .

Inherited cavernous malformations of the central nervous system: clinical and genetic features in 19 Swiss families

F. Andermann, D. Verlaan, A. Siegel, 2009, Neurosurgical Review.

[Familial cavernous malformations of the central nervous system. A clinical and genetic study of 15 German families].

J. Dichgans, F. Andermann, J. Schramm, 2005, Der Nervenarzt.

Interaction between genetic and epigenetic variation defines gene expression patterns at the asthma-associated locus 17q12-q21 in lymphoblastoid cell lines

T. Pastinen, D. Sinnett, D. Verlaan, 2012, Human Genetics.

Targeted screening of cis-regulatory variation in human haplotypes.

K. Dewar, T. Pastinen, Nicolas W. Martin, 2008, Genome research.

Genome-wide assessment of imprinted expression in human cells

K. Gunderson, A. Montpetit, Dmitry Pokholok, 2011, Genome Biology.

A cis-Acting Regulatory Variant in the IL2RA Locus1

H. Hakonarson, T. Hudson, C. Polychronakos, 2009, The Journal of Immunology.

Large germline deletions and duplication in isolated cerebral cavernous malformation patients

U. Felbor, D. Verlaan, A. Siegel, 2007, Neurogenetics.

CCM3 mutations are uncommon in cerebral cavernous malformations

C. Elger, D. Verlaan, A. Siegel, 2005, Neurology.

No CCM2 mutations in a cohort of 31 sporadic cases

D. Verlaan, A. Siegel, G. Rouleau, 2004, Neurology.

No CCM2 mutations in a cohort of 31 sporadic cases

D. Verlaan, A. Siegel, G. Rouleau, 2004, Neurology.

Linkage to the CCM2 Locus and Genetic Heterogeneity in Familial Cerebral Cavernous Malformation

J. Dichgans, D. Verlaan, A. Siegel, 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Cerebral cavernous malformations: Mutations in Krit1

D. Verlaan, A. Siegel, G. Rouleau, 2002, Neurology.

Interaction between genetic and epigenetic variation defines gene expression patterns at the asthma-associated locus 17q12-q21 in lymphoblastoid cell lines

T. Pastinen, D. Sinnett, D. Verlaan, 2012, Human Genetics.

A novel duplication confirms the involvement of 5q23.2 in autosomal dominant leukodystrophy.

J. Bouchard, D. Verlaan, G. Rouleau, 2008, Archives of neurology.

Locus IL 2 RA-Acting Regulatory Variant in the cis A

H. Hakonarson, T. Hudson, C. Polychronakos, 2009 .

Promoter polymorphisms in CHI3L1 are associated with asthma.

T. Pastinen, D. Sinnett, D. Sirois-Gagnon, 2012, The Journal of allergy and clinical immunology.

Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.

C. Liquori, D. Verlaan, A. Siegel, 2003, American journal of human genetics.

The 14q restless legs syndrome locus in the French Canadian population

A. Desautels, J. Montplaisir, M. Dubé, 2004, Annals of neurology.

CCM2 mutations account for 13% of cases in a large collection of kindreds with hereditary cavernous malformations

C. Liquori, D. Verlaan, A. Siegel, 2004, Annals of neurology.

CCM1 mutation screen of sporadic cases with cerebral cavernous malformations

F. Andermann, D. Verlaan, A. Siegel, 2004, Neurology.

A new locus for autosomal dominant intracranial aneurysm, ANIB4, maps to chromosome 5p15.2-14.3

M. Dubé, D. Verlaan, G. Rouleau, 2006, Journal of Medical Genetics.

A mutation in the HSN2 gene causes sensory neuropathy type II in a Lebanese family

Jean-Baptiste Rivière, Dominique J Verlaan, Masoud Shekarabi, 2004, Annals of neurology.

A novel locus for idiopathic generalized epilepsy in French‐Canadian families maps to 10p11

L. Carmant, M. Dubé, D. Verlaan, 2008, American journal of medical genetics. Part A.

Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study

A Hofman, P Deloukas, TD Spector, 2008, The Lancet.

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture

Daniel L. Koller, D. Kiel, A. Uitterlinden, 2012, Nature Genetics.

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture

Daniel L. Koller, D. Kiel, A. LaCroix, 2012, Nature Genetics.

A novel locus for idiopathic generalized epilepsy in French‐Canadian families maps to 10p11

L. Carmant, M. Dubé, D. Verlaan, 2008, American journal of medical genetics. Part A.